中文 | English
Return
Total: 250 , 1/25
Show Home Prev Next End page: GO
Author:(Yaping XU)

1.Proceedings of MinK-related peptides

Xianghua XU ; Yaping PAN

Chinese Pharmacological Bulletin 2003;0(10):-

2.EGFR targeted inhibitors in esophageal cancer

Xiaojiang SUN ; Yaping XU

Journal of International Oncology 2010;37(12):922-925

3.Clinical Observation of Ornidazole Combined with Jinzhi Jieyin Gargle in the Treatment of Acute Wisdom Tooth Pericoronitis

Yaping LI ; Qinghui XU

China Pharmacy 2016;(6):737-739

4.Comparison of EPBD and EPBD combined with SEST in treatment of large choledocholithiasis

Lisheng TAO ; Yaping XU ; Jun YAO

China Journal of Endoscopy 2017;23(6):82-86

5.Proceedings of the two-pore domain K~+ channel

Yaping PAN ; Xianghua XU ; Xiaoliang WANG ;

Chinese Pharmacological Bulletin 1986;0(04):-

6.Inhibitory effects of survivin antisense oligonucleotide on human endometrial carcinoma cells

Jinyu XU ; Yaping CHEN ; Bingjin CHEN

Fudan University Journal of Medical Sciences 2009;36(6):723-726

7.Clinical progress for the EGFR-TKI combined with radiotherapy in non-small cell lung cancer

Juan LIN ; Shuiyun HAN ; Yaping XU

Journal of Chinese Physician 2016;18(6):813-817

8.Application of hypofractionated conformal radiotherapy in non-small cell lung cancer

Liming SHENG ; Yaping XU ; Shenglin MA

Journal of International Oncology 2011;38(5):374-376

9.Laser Ablation-Inductively Coupled Plasma-Mass Spectrometer:A Quantification Strategy Based on Two Reference Materialsand Bulk Normalization as 100% (wt)

Shitou WU ; Yaping WANG ; Chunxue XU

Chinese Journal of Analytical Chemistry 2017;45(7):965-972

10.Application of FDG PET-CT in chemoradiotherapy for esophageal cancer

Feiying GU ; Chenxue JIANG ; Yaping XU

Chinese Journal of Radiation Oncology 2017;26(8):961-964

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 250 , 1/25 Show Home Prev Next End page: GO